MRK

Merck & Co.

$94.97

-1.46 (-1.51%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 20.11.2025
$102.54
(+7.97%)
Strong Buy: 2
Buy: 12
Hold: 13
Sell: 0
Strong Sell: 0
Description:
Merck & Company Inc. is a leading American multinational pharmaceutical corporation based in Kenilworth, New Jersey, renowned for its commitment to advancing global health through innovative pharmaceuticals and vaccines. Founded in 1891, the company has a distinguished history of scientific breakthroughs, primarily focusing on oncology, infectious diseases, and cardiovascular therapeutics. Merck maintains a strong clinical pipeline and invests heavily in research and development, solidifying its status as a frontrunner in the biopharmaceutical industry. With a dedication to improving patient outcomes and ensuring healthcare accessibility, Merck leverages its scientific expertise and strategic partnerships to navigate the dynamic healthcare landscape, positioning itself for sustained growth and innovation.
Exchange:
NYSE
Country:
USA
Sector:
HEALTHCARE
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
126 EAST LINCOLN AVENUE, RAHWAY, NJ, UNITED STATES, 07065
Fiscal year end:
December
Market capitalization:
$241 Billion
EBITDA:
$31.5 Billion
PERatio:
12.76
EPS:
7.56
Dividend per share:
$3.20
Dividend yield:
3.45%
Beta:
0.319

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+125%
How much will you get:
$2,246
Prices dates:
30-10-2015: $38.29 and 31-10-2025: $85.98